INmune Bio, Inc. (INMB) Earnings
|
Expand Research on INMB
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -34.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +2.0% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/6/26  |
Q425 | N/A | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/4/26 |
Q425 | N/A | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/2/26 |
Q425 | N/A | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/26/26 |
Q425 | N/A | -$0.24 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 10/30/25 | Q325 | -$0.24 | -$0.33 | +$0.09 | N/A | N/A | N/A |  | | Details | |
| 8/7/25 | Q225 | -$1.05 | -$0.40 | -$0.65 | N/A | $3K | N/A | | | Details | |
| 7/30/25 |
Q225 | N/A | -$0.40 | N/A | N/A | $3K | N/A | N/A | N/A | ||
| 4/30/25 |
Q125 | N/A | -$0.49 | N/A | N/A | N/A | N/A | N/A | N/A |
